Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Ketorolac Tromethamine Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Ketorolac Tromethamine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Ketorolac Tromethamine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Ketorolac Tromethamine Market Size Growth Rate by Type
    • 1.4.2 Injection
    • 1.4.3 Ophthalmic
    • 1.4.4 Nasal
    • 1.4.5 Oral tablet
  • 1.5 Market by Application
    • 1.5.1 Global Ketorolac Tromethamine Market Size Growth Rate by Application
    • 1.5.2 Short-term treatment of pain
    • 1.5.3 Ophthalmic Surgery
  • 1.6 Coronavirus Disease 2019 (Covid-19): Ketorolac Tromethamine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Ketorolac Tromethamine Industry
      • 1.6.1.1 Ketorolac Tromethamine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Ketorolac Tromethamine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Ketorolac Tromethamine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Ketorolac Tromethamine Market Size Estimates and Forecasts
    • 2.1.1 Global Ketorolac Tromethamine Revenue 2015-2026
    • 2.1.2 Global Ketorolac Tromethamine Sales 2015-2026
  • 2.2 Ketorolac Tromethamine Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Ketorolac Tromethamine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Ketorolac Tromethamine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ketorolac Tromethamine Competitor Landscape by Players

  • 3.1 Ketorolac Tromethamine Sales by Manufacturers
    • 3.1.1 Ketorolac Tromethamine Sales by Manufacturers (2015-2020)
    • 3.1.2 Ketorolac Tromethamine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Ketorolac Tromethamine Revenue by Manufacturers
    • 3.2.1 Ketorolac Tromethamine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Ketorolac Tromethamine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Ketorolac Tromethamine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Ketorolac Tromethamine Revenue in 2019
    • 3.2.5 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Ketorolac Tromethamine Price by Manufacturers
  • 3.4 Ketorolac Tromethamine Manufacturing Base Distribution, Product Types
    • 3.4.1 Ketorolac Tromethamine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Ketorolac Tromethamine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Ketorolac Tromethamine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Ketorolac Tromethamine Market Size by Type (2015-2020)
    • 4.1.1 Global Ketorolac Tromethamine Sales by Type (2015-2020)
    • 4.1.2 Global Ketorolac Tromethamine Revenue by Type (2015-2020)
    • 4.1.3 Ketorolac Tromethamine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Ketorolac Tromethamine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Ketorolac Tromethamine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Ketorolac Tromethamine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Ketorolac Tromethamine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Ketorolac Tromethamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Ketorolac Tromethamine Market Size by Application (2015-2020)
    • 5.1.1 Global Ketorolac Tromethamine Sales by Application (2015-2020)
    • 5.1.2 Global Ketorolac Tromethamine Revenue by Application (2015-2020)
    • 5.1.3 Ketorolac Tromethamine Price by Application (2015-2020)
  • 5.2 Ketorolac Tromethamine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Ketorolac Tromethamine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Ketorolac Tromethamine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Ketorolac Tromethamine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Ketorolac Tromethamine by Country
    • 6.1.1 North America Ketorolac Tromethamine Sales by Country
    • 6.1.2 North America Ketorolac Tromethamine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Ketorolac Tromethamine Market Facts & Figures by Type
  • 6.3 North America Ketorolac Tromethamine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Ketorolac Tromethamine by Country
    • 7.1.1 Europe Ketorolac Tromethamine Sales by Country
    • 7.1.2 Europe Ketorolac Tromethamine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Ketorolac Tromethamine Market Facts & Figures by Type
  • 7.3 Europe Ketorolac Tromethamine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Ketorolac Tromethamine by Region
    • 8.1.1 Asia Pacific Ketorolac Tromethamine Sales by Region
    • 8.1.2 Asia Pacific Ketorolac Tromethamine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Type
  • 8.3 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Ketorolac Tromethamine by Country
    • 9.1.1 Latin America Ketorolac Tromethamine Sales by Country
    • 9.1.2 Latin America Ketorolac Tromethamine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Ketorolac Tromethamine Market Facts & Figures by Type
  • 9.3 Central & South America Ketorolac Tromethamine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Ketorolac Tromethamine by Country
    • 10.1.1 Middle East and Africa Ketorolac Tromethamine Sales by Country
    • 10.1.2 Middle East and Africa Ketorolac Tromethamine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description, Business Overview and Total Revenue
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Ketorolac Tromethamine Products Offered
    • 11.1.5 Pfizer Recent Development
  • 11.2 Omeros Corporation
    • 11.2.1 Omeros Corporation Corporation Information
    • 11.2.2 Omeros Corporation Description, Business Overview and Total Revenue
    • 11.2.3 Omeros Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Omeros Corporation Ketorolac Tromethamine Products Offered
    • 11.2.5 Omeros Corporation Recent Development
  • 11.3 Egalet US Inc.
    • 11.3.1 Egalet US Inc. Corporation Information
    • 11.3.2 Egalet US Inc. Description, Business Overview and Total Revenue
    • 11.3.3 Egalet US Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Egalet US Inc. Ketorolac Tromethamine Products Offered
    • 11.3.5 Egalet US Inc. Recent Development
  • 11.4 Allergan
    • 11.4.1 Allergan Corporation Information
    • 11.4.2 Allergan Description, Business Overview and Total Revenue
    • 11.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Allergan Ketorolac Tromethamine Products Offered
    • 11.4.5 Allergan Recent Development
  • 11.5 Dr. Reddy’s Laboratories
    • 11.5.1 Dr. Reddy’s Laboratories Corporation Information
    • 11.5.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
    • 11.5.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Products Offered
    • 11.5.5 Dr. Reddy’s Laboratories Recent Development
  • 11.6 Teva
    • 11.6.1 Teva Corporation Information
    • 11.6.2 Teva Description, Business Overview and Total Revenue
    • 11.6.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Teva Ketorolac Tromethamine Products Offered
    • 11.6.5 Teva Recent Development
  • 11.7 Mylan
    • 11.7.1 Mylan Corporation Information
    • 11.7.2 Mylan Description, Business Overview and Total Revenue
    • 11.7.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Mylan Ketorolac Tromethamine Products Offered
    • 11.7.5 Mylan Recent Development
  • 11.8 West Ward Pharmaceuticals
    • 11.8.1 West Ward Pharmaceuticals Corporation Information
    • 11.8.2 West Ward Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.8.3 West Ward Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Products Offered
    • 11.8.5 West Ward Pharmaceuticals Recent Development
  • 11.9 Fresenius Kabi
    • 11.9.1 Fresenius Kabi Corporation Information
    • 11.9.2 Fresenius Kabi Description, Business Overview and Total Revenue
    • 11.9.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Fresenius Kabi Ketorolac Tromethamine Products Offered
    • 11.9.5 Fresenius Kabi Recent Development
  • 11.10 Apotex
    • 11.10.1 Apotex Corporation Information
    • 11.10.2 Apotex Description, Business Overview and Total Revenue
    • 11.10.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Apotex Ketorolac Tromethamine Products Offered
    • 11.10.5 Apotex Recent Development
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description, Business Overview and Total Revenue
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Ketorolac Tromethamine Products Offered
    • 11.1.5 Pfizer Recent Development
  • 11.12 Amphastar Pharmaceuticals
    • 11.12.1 Amphastar Pharmaceuticals Corporation Information
    • 11.12.2 Amphastar Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.12.3 Amphastar Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Amphastar Pharmaceuticals Products Offered
    • 11.12.5 Amphastar Pharmaceuticals Recent Development
  • 11.13 Gland Pharma Limited
    • 11.13.1 Gland Pharma Limited Corporation Information
    • 11.13.2 Gland Pharma Limited Description, Business Overview and Total Revenue
    • 11.13.3 Gland Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Gland Pharma Limited Products Offered
    • 11.13.5 Gland Pharma Limited Recent Development
  • 11.14 Akorn
    • 11.14.1 Akorn Corporation Information
    • 11.14.2 Akorn Description, Business Overview and Total Revenue
    • 11.14.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Akorn Products Offered
    • 11.14.5 Akorn Recent Development
  • 11.15 Sun Pharmaceutical
    • 11.15.1 Sun Pharmaceutical Corporation Information
    • 11.15.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
    • 11.15.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Sun Pharmaceutical Products Offered
    • 11.15.5 Sun Pharmaceutical Recent Development
  • 11.16 Sagent Pharmaceuticals
    • 11.16.1 Sagent Pharmaceuticals Corporation Information
    • 11.16.2 Sagent Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.16.3 Sagent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Sagent Pharmaceuticals Products Offered
    • 11.16.5 Sagent Pharmaceuticals Recent Development
  • 11.17 Aurobindo Pharma
    • 11.17.1 Aurobindo Pharma Corporation Information
    • 11.17.2 Aurobindo Pharma Description, Business Overview and Total Revenue
    • 11.17.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Aurobindo Pharma Products Offered
    • 11.17.5 Aurobindo Pharma Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Ketorolac Tromethamine Market Estimates and Projections by Region
    • 12.1.1 Global Ketorolac Tromethamine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Ketorolac Tromethamine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Ketorolac Tromethamine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Ketorolac Tromethamine Sales Forecast (2021-2026)
    • 12.2.2 North America: Ketorolac Tromethamine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Ketorolac Tromethamine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Ketorolac Tromethamine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Ketorolac Tromethamine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Ketorolac Tromethamine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Ketorolac Tromethamine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Ketorolac Tromethamine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Ketorolac Tromethamine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Ketorolac Tromethamine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Ketorolac Tromethamine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Ketorolac Tromethamine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Ketorolac Tromethamine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Ketorolac Tromethamine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Ketorolac Tromethamine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Ketorolac Tromethamine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Ketorolac Tromethamine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Ketorolac Tromethamine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ketorolac Tromethamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Ketorolac Tromethamine market is segmented into
    Injection
    Ophthalmic
    Nasal
    Oral tablet

    Segment by Application, the Ketorolac Tromethamine market is segmented into
    Short-term treatment of pain
    Ophthalmic Surgery

    Regional and Country-level Analysis
    The Ketorolac Tromethamine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Ketorolac Tromethamine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Ketorolac Tromethamine Market Share Analysis
    Ketorolac Tromethamine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ketorolac Tromethamine business, the date to enter into the Ketorolac Tromethamine market, Ketorolac Tromethamine product introduction, recent developments, etc.
    The major vendors covered:
    Pfizer
    Omeros Corporation
    Egalet US Inc.
    Allergan
    Dr. Reddy’s Laboratories
    Teva
    Mylan
    West Ward Pharmaceuticals
    Fresenius Kabi
    Apotex
    Sandoz
    Amphastar Pharmaceuticals
    Gland Pharma Limited
    Akorn
    Sun Pharmaceutical
    Sagent Pharmaceuticals
    Aurobindo Pharma

    Buy now